- Home
- PDT vs CRMD Comparison
PDT vs CRMD Comparison
Compare PDT & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDT
- CRMD
- Stock Information
- Founded
- PDT 1989
- CRMD 2006
- Country
- PDT United States
- CRMD United States
- Employees
- PDT N/A
- CRMD N/A
- Industry
- PDT Finance Companies
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- PDT Finance
- CRMD Health Care
- Exchange
- PDT Nasdaq
- CRMD Nasdaq
- Market Cap
- PDT 648.3M
- CRMD 576.4M
- IPO Year
- PDT N/A
- CRMD 2010
- Fundamental
- Price
- PDT $12.35
- CRMD $8.46
- Analyst Decision
- PDT
- CRMD Strong Buy
- Analyst Count
- PDT 0
- CRMD 5
- Target Price
- PDT N/A
- CRMD $15.20
- AVG Volume (30 Days)
- PDT 145.6K
- CRMD 896.1K
- Earning Date
- PDT 01-01-0001
- CRMD 10-30-2024
- Dividend Yield
- PDT 8.88%
- CRMD N/A
- EPS Growth
- PDT N/A
- CRMD N/A
- EPS
- PDT N/A
- CRMD N/A
- Revenue
- PDT N/A
- CRMD $12,262,234.00
- Revenue This Year
- PDT N/A
- CRMD N/A
- Revenue Next Year
- PDT N/A
- CRMD $277.75
- P/E Ratio
- PDT N/A
- CRMD N/A
- Revenue Growth
- PDT N/A
- CRMD 41184.20
- 52 Week Low
- PDT $8.77
- CRMD $2.89
- 52 Week High
- PDT $13.05
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- PDT 28.74
- CRMD 36.17
- Support Level
- PDT $12.26
- CRMD $8.12
- Resistance Level
- PDT $13.08
- CRMD $9.54
- Average True Range (ATR)
- PDT 0.18
- CRMD 0.45
- MACD
- PDT -0.08
- CRMD -0.13
- Stochastic Oscillator
- PDT 4.93
- CRMD 23.17
About PDT John Hancock Premium Dividend Fund
John Hancock Premium Div Fund II is a United States-based closed-end management investment company. It seeks to provide a high current income consistent with modest growth of capital. The fund will pursue its objective by investing in a diversified portfolio comprised of dividend-paying preferred securities and common equity securities. The portfolio composition of the fund consists of preferred securities, common stocks, corporate bonds, and short-term investments.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.